Flueggea virosa
Flueggea virosa · Accepted scientific name
Scientific literature: Very Sparse (5 studies) · ★☆☆☆☆
Flueggea virosa is a versatile medicinal plant known for its significant therapeutic potential in treating various health conditions. The leaves and roots of this species contain vital bioactive chemicals, including virosecurinine, bergenin, (-)-Norsecurinine, and cardiac glycosides. Through various preparations such as acetone extracts, petroleum spirit extracts, butanol fractions, and chloroform extracts, researchers have identified its potent antiplasmodial, antimalarial, antiviral, and cytotoxic activities. These pharmacological properties make the plant a promising candidate for managing malaria, epilepsy, and gastrointestinal diseases. Furthermore, its demonstrated antioxidant activity highlights its importance in holistic medicinal applications.
- Synonyms
- Acidoton Virosus · Securinega Virosa · 1 more
- Common names
- Not available
- Family
- Phyllanthaceae
- Distribution
- Northern America
- Plant Parts
- Leaf · Root
Classification
Synonyms
Flueggea virosa is a plant species that is known by several different botanical names throughout scientific literature. Due to historical taxonomic reclassifications, it is frequently referred to by the synonym Acidoton virosus. Researchers may also encounter this same plant documented under the name Phyllanthus virosus. Additionally, the species has been identified in various records as Securinega virosa. Understanding these overlapping synonyms is essential for ensuring accurate identification and consistent communication within the botanical community.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Flueggea virosa belongs to the vast kingdom Plantae, representing a diverse branch of the living world. Within this biological classification, the species is categorized under the class Equisetopsida. It further descends through the order Malpighiales, showcasing its specific evolutionary lineage. As a member of the family Phyllanthaceae, it shares distinct structural characteristics with its close relatives. Ultimately, this plant is identified by its unique placement within the genus Flueggea.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Malpighiales |
| Family | Phyllanthaceae |
| Genus | Flueggea |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Flueggea virosa is a plant species widely distributed across various regions of the African continent. Within East Tropical Africa, it can be found thriving in the landscapes of Kenya, Tanzania, and Uganda. Its presence extends further into Northeast Tropical Africa, where it inhabits the terrain of Chad. Additionally, the species is documented growing in the unique environment of Djibouti. This broad geographic range highlights the plant's adaptability to diverse African ecosystems.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Flueggea virosa is a versatile plant characterized by its distinct shrub growth form. As a self-supporting species, it maintains its structure independently within its natural habitat. This plant exhibits significant variation in size, with heights ranging from a mere 0.3 m to a maximum of 7.5 m. While it can be quite small, it frequently reaches a more substantial stature of at least 3.375 m. Such diverse dimensions allow this shrub to adapt effectively to various environmental conditions.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Flueggea virosa has emerged as a significant plant in ethnopharmacological research due to its diverse range of therapeutic properties. Studies conducted in Kenya and Zimbabwe have confirmed its potent antiplasmodial activity against both sensitive and resistant strains of Plasmodium falciparum. Furthermore, the plant demonstrates strong antimalarial efficacy, with specific extracts showing the ability to suppress parasite growth in animal models. Beyond malaria, in silico screening has identified securinol A from the species as a potential candidate for antiviral applications against the dengue virus. Finally, the plant's biological profile is characterized by its cytotoxic activity, highlighting its potential for further development in medicinal chemistry.
Compounds
Flueggea virosa, also known as Securinega virosa, is a medicinal plant rich in various bioactive secondary metabolites. Research has identified several key alkaloids within the species, including norsecurinine, virosecurinine, and the novel flueggenines. Additionally, the plant contains the compound bergenin, which has demonstrated significant sleep-inducing and antimalarial properties. Phytochemical screenings of its extracts further reveal the presence of diverse chemical classes such as flavonoids and cardiac glycosides. These diverse constituents contribute to the plant's traditional use in managing various pathologies, ranging from mental illnesses to parasite infections.
Conditions
Flueggea virosa demonstrates significant therapeutic potential, notably in its ability to treat malaria through various extracts and active constituents like bergenin. This plant has shown effectiveness against the P. berghei parasite in vivo and has been proven to treat the chloroquine-resistant K1 strain of Plasmodium falciparum. Beyond its antimalarial properties, certain isolated alkaloids from the species, such as flueggether A and virosinine A, exhibit mild in vitro anti-HIV activity. Additionally, the plant contains compounds like flueggenines A and B that have shown weak activity against the P-388 cell line. Collectively, these findings highlight the diverse medicinal applications of Flueggea virosa against parasitic, viral, and cellular targets.
Preparations
Flueggea virosa is prepared as acetone extracts, which demonstrate high antioxidant activity in radical scavenging assays. The plant is also processed as a petroleum spirit extract to evaluate its antimicrobial and resistance-modifying properties. Additionally, it is prepared as a chloroform extract to test for its potential against bacterial multidrug resistance. Researchers have further utilized a butanol fraction of the plant to investigate its sleep-inducing capabilities. Finally, Flueggea virosa is prepared as a crude ethanol extract to study its effects on the physiological characteristics of parasites.
Parts used
Flueggea virosa is a medicinal plant recognized for its significant pharmacological properties across various anatomical parts. Research indicates that the leaves of the plant possess strong antipsychotic and sedative potentials, making them valuable in managing mental illness. Additionally, leaf extracts have demonstrated high antiplasmodial activity against resistant strains of malaria. The roots of this species are equally important, as decoctions and extracts from the root bark have shown both sedative effects and antimalarial capabilities. Together, these findings highlight the diverse therapeutic utility of both the leaves and roots of Flueggea virosa.